ACHE Antibody (N_term)
- Known as:
- ACHE Antibody (N_term)
- Catalog number:
- AP7853a
- Product Quantity:
- 0.1 mg
- Category:
- -
- Supplier:
- Abgen
- Gene target:
- ACHE Antibody (N_term)
Related genes to: ACHE Antibody (N_term)
- Gene:
- ACHE NIH gene
- Name:
- acetylcholinesterase (Cartwright blood group)
- Previous symbol:
- YT
- Synonyms:
- -
- Chromosome:
- 7q22.1
- Locus Type:
- gene with protein product
- Date approved:
- 1989-06-02
- Date modifiied:
- 2019-04-23
Related products to: ACHE Antibody (N_term)
Related articles to: ACHE Antibody (N_term)
- Although nearly 80% of Americans reside in a county with a legal, regulated cannabis dispensary, the majority of cannabis consumed in the U.S. is still obtained from unregulated, illicit sources. Illicit cannabis carries greater health risks and is generally less preferred than regulated cannabis, yet its lower price makes it attractive to many customers. However, comparative research on price differentials between the legal and illicit markets across states is scarce. Establishing cannabis price benchmarks is essential to ensure that legal markets are competitively priced and can effectively displace the illicit trade. - Source: PubMed
Publication date: 2026/06/06
Hebert RebeccaBoehnke Kevin FJoshi Spruha - Traumatic diaphragmatic hernia (TDH) may present months to years after blunt injury and can mimic biliary or pulmonary disease. Right-sided TDH is particularly prone to delayed recognition because partial hepatic herniation may be overlooked unless the diaphragm is specifically reviewed. - Source: PubMed
Publication date: 2026/06/05
Yun JihyongRyu SangwanYoon Cheesoon - Sepsis-associated encephalopathy (SAE), a devastating neurological complication of systemic inflammation, affects approximately 70% of patients with sepsis. It not only increases mortality but also leaves survivors with persistent cognitive deficits. However, the mechanisms underlying SAE progression remain incompletely understood. Here, using a lipopolysaccharide (LPS)-induced mouse model of SAE, we identify microglial galectin-3 (Gal-3) as a central pathogenic mediator driving systemic inflammation-induced cognitive impairment. Mechanistically, systemic LPS challenge robustly upregulates microglial Gal-3, which in turn activates Toll-like receptor 2 (TLR2) signaling and promotes NLRP3/AIM2 inflammasome assembly. This microglia-driven inflammatory cascade substantially exacerbates local oxidative stress, leading to selective structural and functional impairment of hippocampal parvalbumin (PV) interneurons. Dysfunction of these critical interneurons disrupts theta/gamma oscillations, impairs excitatory/inhibitory (E/I) balance and synaptic plasticity, and ultimately results in severe cognitive decline. Supporting this pathogenic cascade, pharmacological inhibition of Gal-3 with TD139 effectively suppresses TLR2/inflammasome activation, attenuates oxidative stress, and prevents memory deficits. Conversely, targeted rAAV-mediated overexpression of Gal-3 in microglia is sufficient to recapitulate neuroinflammation, PV-interneuron injury, oscillatory abnormalities, and cognitive impairment. Finally, chemogenetic reactivation of hippocampal PV interneurons using DREADDs restores theta/gamma oscillations and ameliorates LPS-induced cognitive deficits. Together, our findings define a coherent pathogenic axis linking microglial Gal-3 upregulation to PV interneuron-dependent network desynchronization and highlight Gal-3 as a promising therapeutic target for inflammation-associated cognitive disorders. - Source: PubMed
Publication date: 2026/06/05
Jia MinShao HuaMa Si-QiLiu Wen-XueCai MengZhu TongXu ShanLi Gui-ZhouLu Shuai-FeiShen Jin-ChunChen JiangShi Yun StoneHashimoto KenjiZhang Guang-FenJi Mu-HuoYang Jian-Jun - Astrocytic activation is critically involved in the development and maintenance of bone cancer pain (BCP). Recent studies have shown that astrocytes participate in synaptic remodeling through synaptic phagocytosis, whereas neuronal cell adhesion molecule (NRCAM) restricts the extension of perisynaptic astrocytic processes and exerts an anti-phagocytic effect. However, whether astrocyte-mediated synaptic phagocytosis contributes to BCP remains to be explored. Hence, this study investigated the role of astrocytic NRCAM deficiency in synaptic remodeling and central sensitization in BCP. - Source: PubMed
Publication date: 2026/06/05
Zhang ZuoxiaHou YunfanMao YantingJiang LiLu Cui'eYu JiachengHuang YulinXu RuiHuang SiminZhang XiaoZhu HuijieZhang WeiSun Yu'eMa Zhengliang - Allogeneic blood is a limited and globally scarce resource. Protocols based on the Patient Blood Management (PBM) program, incorporating therapeutic alternatives to reduce the use of red blood cells (RBCs), fresh frozen plasma (FFP), and platelet concentrates (PCs), have become urgently needed. The aims of this study were: as a primary objective, to evaluate whether the implementation of a Patient Blood Management (PBM) protocol reduces allogeneic transfusion in patients undergoing coronary artery bypass grafting (CABG); and as a secondary objective, to assess the impact of transfusion on clinical outcomes and mortality following CABG surgery. - Source: PubMed
Publication date: 2026/06/05
Alceu Dos Santos AntonioHossne Junior Nelson AmericoGomes Walter JoséGuizilini Solangeda Silva Gilmara SilveiraCastro Rodrigo MoreiraBezerra Rodrigo FreireColosimo Flávia CortezFigueiredo Maria StellaBarros Melca Maria Oliveirade Cássia Rodrigues RitaLamim Regiane ChiavelliPanfilio Carlos EduardoCéspedes Isabel Cristina